Mode
Text Size
Log in / Sign up

Review Proposes Gut Microbiota-Ferroptosis Axis in PCOS and Potential TCM RoleReview explores gut bacteria link to PCOS and potential role of Chinese herbal medicine

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret this review as a theoretical exploration of a potential PCOS mechanism, not as clinical evidence.

A systematic review article explores the scientific rationale for a gut microbiota-ferroptosis axis in the pathophysiology of polycystic ovary syndrome (PCOS). The review proposes that gut microbiota dysbiosis may act as a potential upstream trigger, disrupting iron homeostasis and reducing antioxidant metabolites like short-chain fatty acids. This is theorized to exacerbate oxidative stress, induce ferroptosis in ovarian granulosa cells, and contribute to impaired follicular development and insulin resistance.

The review identifies Traditional Chinese Medicine (TCM) monomers and compounds, including berberine and quercetin, as having significant potential to regulate gut microbiota and inhibit ferroptosis. The authors suggest TCM may offer benefits as an adjunct or alternative to conventional PCOS therapies. No specific clinical trial data, effect sizes, or patient outcomes are reported to support this therapeutic potential.

Safety and tolerability data for TCM interventions in this context are not reported. Key limitations stem from the review's nature: it presents a theoretical perspective and explores mechanisms and application prospects rather than reporting new experimental or clinical trial results. It does not establish causation. The population, sample size, study setting, comparator, and follow-up duration are all not reported.

For clinical practice, this review highlights an area of active mechanistic research but provides no evidence for changing current management. The proposed axis and therapeutic role of TCM remain speculative and require rigorous clinical investigation.

A recent scientific review looked at a possible connection between gut bacteria, a process called ferroptosis, and polycystic ovary syndrome (PCOS). The authors propose that an imbalance in gut bacteria might disrupt the body's iron balance and reduce protective substances, leading to increased cell stress in the ovaries. This stress, known as ferroptosis, could then harm egg development and contribute to insulin resistance, which are common issues in PCOS.

The review also explored whether certain Traditional Chinese Medicine (TCM) compounds, like berberine and quercetin, could help. The authors suggest these natural substances might have the potential to rebalance gut bacteria and reduce the harmful ferroptosis process. However, the review did not involve new experiments or patient studies to test this idea directly.

It is important to understand that this article is a theoretical discussion. It connects existing scientific ideas to propose a new way of thinking about PCOS, but it does not provide new proof from clinical trials. The authors are suggesting a possible future direction for research, not reporting on treatments that have been proven to work in people with PCOS yet.

Readers should see this as an early-stage scientific hypothesis. While the ideas about gut health and natural compounds are interesting, they remain unproven for treating PCOS. More research, especially studies involving patients, is needed to see if targeting this gut-ferroptosis connection could become a real treatment option.

What this means for you:
A review proposes a new theory linking gut bacteria to PCOS, but this idea needs testing in clinical trials.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Polycystic ovary syndrome (PCOS) is a complex reproductive endocrine metabolic disorder whose pathogenesis remains incompletely understood. In recent years, the role of ferroptosis–a novel form of iron-dependent programmed cell death–in the pathogenesis of PCOS has gradually drawn attention. This review proposes an innovative perspective: gut microbiota dysbiosis may be a potential upstream trigger of ferroptosis in PCOS ovarian granulosa cells. Microbiome dysbiosis disrupts iron homeostasis and reduces the production of antioxidant metabolites such as short-chain fatty acids (SCFAs) and bile acids (BAs), thereby exacerbating systemic and local ovarian oxidative stress. This induces ferroptosis, leading to impaired follicular development and insulin resistance. Traditional Chinese Medicine (TCM) demonstrates significant potential in regulating gut microbiota and inhibiting ferroptosis. Based on this, this study explores the role of the gut microbiota-ferroptosis axis in PCOS, focusing on the scientific rationale and application prospects of treating PCOS by intervening in this axis using TCM monomers and compounds such as berberine and quercetin. With its multi-target regulatory effects and favorable safety profile, TCM may offer benefits as an adjunct or alternative to conventional therapies. This research aims to provide theoretical references for developing novel therapeutic strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.